The type II nuclear estrogen receptor of the mammalian uterus was first identified by Eriksson et.ai, (1978) several years ago Subsequent studies carried out by Clark and his associates revealed that the presence of this receptor was closely linked to active transcription and cellular proliferation in the rat uterus (Clark et.ai, 1979; Markaverich et.ai, 1989; Markaverich et.ai, 1990) . In comparison to the regular nuclear estrogen receptor homodimer, this receptor possessed greater capacity for estradiol binding, with a concomitant reduction in its affinity. Purification and characterization of the type II estrogen receptor posed a challenging task to investigators for several years.
During his studies on the rat uterine estrogen receptor activation factor (E-RAF), Thampan observed that the nuclear type II estrogen receptor was predominantly associated with the nuclear RNA polymearses and also that it was incapable of binding to the DNA (Thampan, 1983; 1989) . It was this observation that prompted us to design a method for the purification of the estrogen receptor, type-II. we have succeeded in our attempt to purify and characterize this nuclear receptor (Karthikeyan and Thampan 1994a; chapter III of this thesis). However, in order to avoid controversies we decided to name it as R-II.
Purification and characterization of the goat uterine non-activated estrogen receptor (naER) has been accomplished (Anuradha et.ai, 1994; Karthikeyan and Thampan 1994b ; chapter IV of this thesis). It was the absolute identity observed in the procedures employed in the purification of the cytosolic naER and those of the nuclear R-II that projected the question as to whether the two proteins were one and the same.
Nevertheless, the noticeable differences between the hormone binding characteristics and the structural features of the naER and those of the R-II served to abandon, temporarily, experiments aimed to test this view point. The discovery of the glycoprotein nature of the naER (Karthikeyan and Thampan 1994b; chapter IV of this thesis) and of the absence of carbohydrate residues in the R-II served to re-initiate this line of thought. With the results presented in this chapter I feel that I have nearly succeeded in identifying the precursor-product relationship that exists between the cytosolic naER and the nuclear R-II, respectively.
As mentioned earlier, in the previous chapter, it is imperative that a hormone binding protein comes to be identified as a hormone receptor only when the hormone-protein interaction is shown to lead to a cascade of biological responses. The present evidences show that the R-II binds to the nucleaar RNA porymearse n. Whether this interaction will result in activation of the RNA porymearse and the consequent enhancement in the expression of a given gene can not be addressed at this stage, since I do not have the neccessary experimental evidence now. It requires additional experimentation to understand the molecular biology of the R-II. Till then the use of the terminology receptor' for this high affinity estrogen-binding protein may not seem realistic.
RESULTS

PURIFICATION OF NUCLEAR ESTROGEN RECEPTOR R-II:
Using the method published earlier (Karthikeyan and Thampan, 1994a ; chapter III of theis thesis) it was not possible to isolate a highly pure preparation of nuclear R-II receptor since a 55 kDa protein, presumably a proteolytic product of the R-II, copurified with the 66 kDa protein. In the modified procedure presented here a phosphocellulose chromatography step has been introduced. This was the only change that was introduced when the original naER isolation procedure (Anuradha ei.al., 1994) was modified. As a result I have succeeded in isolating a highly purified preparation of R-II ( Fig.23 ; SDS gel given in Fig.28 ).
COMPARATIVE STUDIES USING R-II AND naER: A). SATURATION BINDING OF ESTRADIOL:
The saturation binding data for the naER showed a parabolic curve while that for the R-II had a sigmoidal shape (Fig.24) . While saturation in hormone binding to naER was achieved in the presence of 15-16nM estradiol, saturation binding to R-II required double this concentration of estradiol, 30-40nM.
BV STOKES RADIUS AND SEDIMENTATION COEFFICIENT:
Stokes radii of R-II and naER were calculated following chromatography of the proteins on a column of Sephadex G-100 equilibrated with the TEMN buffer containing 0.3M NaCl. The column was precalibrated. The Stokes radii of the proteins were calculated as described by Siegel and Monty (1966) . While the naER displayed a Stokes radius of 36OA, the R-II showed a value of 22oA for its Stokes radius (Fig.25) . While naER showed a sedimentation value of 4.6S, the R-II was seen to sediment at 3.8S (Fig.25 inset) .
O. E-RAF DEPENDENT BINDING TO DNA:
Binding of the receptor-hormone complex to DNA, in the presence of varying concentrations of E-RAF was examined. The naER displayed a proportional increase in its DNA binding capacity in response to the increase in the concentration of E-RAF used in the medium until the two proteins arrived at an equimolar concentration (Fig.26) . On the other hand, the R-II failed to bind to the DNA in the presence of E-RAF (Fig.26 ).
D). EXAMINATION OF THE GLYCOPROTEIN IDENTITY:
Two different experimental approaches were made: 1) concanavalin A mediated staining of glycoproteins; 2) chromatography on a column of concanavalin A-Sepharose and elution with a buffer containing methyl a-D-glucopyranoside. As observed earlier (Karthikeyan and Thampan, 1994b ) the naER clearly showed its identity as a glycoprotein. It appeared as a stained protein in the blot and showed excellent capacity to bind to con A-Sepharose, to be eluted with 0.3M methyl a-Dglucopyranoside in TCMMN buffer. On the other hand, there was no glycoprotein identity associated with the nuclear receptors R-II and R-I ( Fig.27 and inset ).
E). PEPTIDE MAPS:
The purified R-II appeared as a single homogeneous band of 66 kDa in silver stained SDS gel (Fig.28) . CNBr peptides of the naER and the R-II were subjected to comparison. The peptide maps displayed by the two proteins were identical (Fig.28) .
The peptide map of the nuclear receptor R-I which is totally different from those of R-II and naER has been shown here for comparison.
EXPERIMENTS TO EXAMINE WHETHER naER COULD BE CONVERTED TO R-II;
The identical methods of purification, the same molecular mass, identical nature of CNBr peptides and the recognition by anti ER IgG of both naER and ER, all pointed towards the fact that the R-II may be a modified naER. Since the major structural difference between the two proteins pertained to the absence of carbohydrate residues associated with the R-II, it was decided to find out whether the naER to R-II conversion could be accomplished by deglycosylating the naER.
The details regarding the reaction media used in the deglycosylation of naER by the glycopeptidase have been given in the 'methods'. Three criteria were examined for the naER to R-II conversion, a) change in the saturation binding data for estradiol binding; b) loss in the capacity of naER to dimerize with E-RAF and the consequent binding to the DNA ;c) alteration in the Stokes radius of the naER, as shown by the chromatographic elution profile on a Sephadex G-100 column. The results are presented in Figure 29 .
The glycopeptidase treatment of the naER caused a distinct change in the estradiol binding properties of the naER. While the control naER showed the typical saturation curve, arriving at saturation binding with 15-16nM estradiol, the glycopeptidase treated protein achieved saturation hormone binding in the presence of 3O-32nM estradiol ( Fig 29A) . Treatment of the naER with the glycopeptidase virtually destroyed its capacity to dimerize with E-RAF and bind to the DNA (Fig.29B) . Also, the enzyme treatment made a significant change in the Stokes radius of the naER, from 36oA to 23 oA (Fig.29C ). The sedimentation values calculated for the treated and untreated naER were 3.9S and 4.6S respectively (data not shown).
RECOGNITION OF R-H, BUT NOT THE R-I BY ANTIPHOSPHOTYROSINE
IgG:
As described earlier (Karthikeyan and Thampan, 1994b; chapter IV of this thesis) for the analysis of the naER using anti phosphotyrosine IgG, two types of experiments were performed: 1) immunorecognition of the receptor immobilized on nitrocellulose membrane by anti phosphotyrosine-BSA IgG; 2) chromatography of the receptor protein on a column of anti phosphotyrosine IgG-Sepharose and the subsequent elution using 0.2M glycine, pH 2.8. The anti phosphotyrosine antibody crossreacted with the R-II, but not with the R-I nuclear estrogen receptor (Fig.30) . Similarly, the R-II but not the R-I was retained by the immunoaffinity column (Fig.30 ).
ASSOCIATION OF TYROSINE KINASE ACTIVITY WITH THE R-II, BUT NOT WITH THE R-l: A). AUTOPHOSPHORYLATION:
An increase in the autophosphorylation of R-II was observed in relation to the increase in the R-II protein concentration employed (Fig.31 A) . No such activity was demonstrated by the R-I (Fig.3 IB) .
B). ANTAGONISM BY ESTROGENS:
The autophosphorylation of R-II was not inhibited by the presence of estradiol or of diethylstilbestrol, a feature in which the R-II differed from the naER (data not shown).
C). EFFECT OF E-RAF:
E-RAF failed to inhibit the R-II autophosphorylation (Fig.31C ). While equimolar concentration of E-RAF totally inhibited naER autophosphorylation ( Fig.31C and D) .
D). EFFECT OF TYRPHOSTIN 25: 86
A graded decrease in the R-Il autophosphorylation was observed in response to an increase in the dose of Tyrphostin 25 employed (Fig.3IE ).
E). IDENTITY OF THE AMINO ACID PHOSPHORYLATED:
The phosphoaminoacid present in the autophosphorylated R-II was identified as phosphotyrosine ( Fig.3IF ).
R-II BINDS TO NUCLEAR RNA POLYMERASE II:
Cytosolic naER and the R-II nuclear estrogen receptors were labeled with fluorescein isothiocyanate and the binding of these proteins to RNA polymerase II was studied as given in the experimental section A very clear binding of R-II to RNA polymerase was observed as demonstrated by increasing transfer of fluroscence from R-II to the RNA polymerase (Fig.32) . The activity was not so pronounced with the naER as it showed only 1/4 the activity that was associated with the R-II.
PHOSPHORYLATION OF RNA POLYMERASE II BY R-II:
The phosphorylation of RNA polymerase was studied both in the presence and in the absence of estrogen receptors. In the absence of any added protein two subunits of the RNA polymerase (molecular mass 105 kDa and 30 kDa) were found phosphorylated. Two additional protiens were found phosphorylatd (molecular mass 66 kDa and 40 kDa) in the presence of naER and two others (molecular mass 91 kDa and 20 kDa in addition to the 40 kDa) in the presence of R-II (Fig.33) . The 66 kDa protein that was observed phosphorylated in the naER-protein kinase system was not observed in the R-II containing media. We have, therefore generated all possible evidences except those regarding the Nterminal / C-terminal residues in order to confirm that R-II is the deglycosylated naER.
The features in which the nuclear R-II differs from the naER are as follows: 1). R-II has no capacity to dimerize with E-RAF. E-RAF forms a heterodimer with naER 2). R-II is not a glycoprotein while naER is one as evidenced by specific staining in the concanavalin A horse radish peroxidase method and also its retention on a con A Sepharose column, to be eluted by methyl a-D-glucopyranoside. estradiol. The much higher capacity of the R-II to bind estradiol in comparison with naER is associated with a drastic reduction in the former's affinity for the hormone. 5). Tyrosine phosphorylation by naER is blocked by its exposure either to estradiol or to E-RAF while these have no influence on the tyrosine phosphorylation effected by R-
II
Since the distinct structural feature in which naER differed from the R-II was the glycoprotein nature of the former, it was decided to examine whether deglycosylaion of naER using a glycopeptidase introduced the necessary structural changes in the protein facilitating its conversion to R-II. The results of the experiments provided positive indications in this direction. Exposure to the glycopeptidase destroyed the capacity of naER to dimerize with E-RAF. The enzyme treatment reduced the Stokes radius of the naER to the R-II level. The enzyme treated naER showed a much higher capacity to bind estradiol than the untreated control.
Possibly, the loss of the carbohydrate associated with naER as a result of the glycopeptidase action brought about irreversible structural changes in the protein.
Consequently a distinct alteration in its shape could have taken place as evidenced by the reduced Stokes radius value The structural changes also may have resulted in the exposure of additional estradiol binding sites characteristic of the R-II receptor. The ultimate result of these changes was the apparent loss of the property of the naER to dimerize with the E-RAF It is possible that the naER to R-II conversion is brought about by a nuclear glycopeptidase. Had this enzyme been present in the cytosol the naER-E-RAF dimerization would not have materialized There is enough experimental evidence to indicate that the two proteins are totally dependent on each other for their nuclear movement. Absence of either one in the medium abolishes the nuclear entry of the surviving protein (Premkumar, 1994) .
The decreased affinity of the naER brought about by its deglycosylution in the nucleus would indicate that the hormone originally bound to the naER in the heterodimer is liable for rapid dissociation. This view is in perfect agreement with the data reported by Clark and colleagues regarding the type II estrogen binding sites of the rat uterus (Clark et.a!., 1979) . In their studies Clark et. ai, (1979) found it not possible to pre label the type-II following its exposure to labelled estradiol as the hormone bound to the receptor dissociated rapidly. It was always necessary to identify its presence in nuclei through nuclear exchange assay or hydroxykinatite binding assay.
The presence or absence of estradiol did not make any difference in the capacity of R-II either to autophosphorylate or phosphorylate RNA polymearse II subunits. This would mean that dissociation of the hormone bound to the naER that occurs as a result of its conversion to R-II is a necessary molecular event, making estradiol available for binding to the type-I estrogen receptor.
There is a distinct difference between the characteristics of the R-II in binding to and phosphorylati ig the RNA polymerase and those of the unmodified naER. In the experiment in which the binding of FITC-labelled naER or R-II to the RNA polymerase II was examined the two proteins were seen to follow a ~ 4:1 ratio in the respective capacities of R-II and naER to bind to the enzyme. The RNA polymerase II 90 is known to have intrinsic protein kinase activity (Edwards, et.al., 1990; Kolodziez et.al., 1990) . This apparently results in the phosphorylation of 105 kDa and 30 kDa subunits of the enzyme. In the presence of naER two additional proteins were seen phosphorylated, of which the 66 kDa protein is most likely the naER itself. The other is the 40 kDa subunit. In addition to the 40 kDa subunits, two others were The fractions containing the peak receptor activity eluted from the hsp 90-Sepharose column (carried out as described in 'methods'), were chromatographed on a phosphocellulose column equilibrated with TEM buffer. The column was washed with TEM buffer. The receptor protein bound to phosphocellulose was eluted using a 0-1M linear NaCl gradient in TEM buffer. The fractions collected were subjected to HAP binding assay. The purified receptor preparations were incubated overnight at 4oC with different concentrations of [3H]-estradiol (4-40nM) + 100 fold molar excess of DES. HAP binding assay was carried out at the end of the incubation. The specific binding activity was calculated for naER (open circles) and R-II (closed circles) by deducting the respective non-specific binding data from the total. Sedimentation values were calculated folowing sucrose density gradient centrifugation and Stokes radii following gel filtration of the proteins on Sephadex G-100. naER is represented by the open circles and the R-II by the closed circles. The purified receptors were incubated overnight (4oC) with [3H] estradiol (20 nM for naER and 40nM for R-II receptor). The hormone receptor complex, isolated following DCC treatment of the incubated media, was further incubated with DNA cellulose in the presence of varying concentrations of E-RAF. The E-RAF dependent DNA cellulose binding assay was carried out as described in materials and methods'. The closed and open circles indicate the activity associated with the naER and the R-II receptor respectively. The purified naER and R-II receptors were chromatographed over a concanavalin A Sepharose column (3ml) equilibrated with TCMMN buffer. The column was washed with the same buffer and the con A-bound proteins were eluted using 0.3M methyl ct-Dglucopyranoside in TCMMN buffer. The eluate, collected in fractions, was measured for its absorbance at 280nm. The closed and open circles indicate the elution profile of naER and that of R-II receptor respectively. The triangles indicate the activity associated with the R-I nuclear estrogen receptor.
The inset is a blot showing con-A dependent staining for carbohydrate moiety. The proteins were transferred to a nitrocellulose membrane. The membrane was processed as described in materials and methods'. 'A' shows the SDS gel of the purified R-II receptor. The fractions containing peak receptor activity eluted from the phosphocellulose column were pooled, concentrated and the proteins precipitated with trichloro acetic acid. The precipitated protein was subjected to electrophoresis on a 10% SDS gel followed by silver staining.
'B\ *C and *D' shows the peptides generated following CNBr fragmentation of naER (B), R-II receptor (C) and R-I receptor (D) respectively. The purified protein (100(ig) was dissolved in lOul of 70% formic acid. To this was added 5mg of solid CNBr. The reaction was allowed to proceed for 60 minutes at room temperature following which it was stopped by the addition of lml of distilled water. The lyophylized proteins were subjected to electrophoresis on a 15% SDS gel. The gels were stained with silver nitrate. 150ug of naER in TEM buffer was incubated with 10 units of glycopeptidase F enzyme as described in "materials and methods'. Upon deglycosylation, NaMo was added to the media to give a concentration of lOmM and the enzyme was separated from the receptor following adsorbtion of the latter to hsp 90-Sepharose equilibrated with TEM buffer containing lOmM NaMo. The matrix was allowed to settle and was washed twice with the NaMo containing buffer. The receptors bound to hsp 90 were eluted with molybdate free TEM buffer. The eluate was used for further analysis. Control samples (not exposed to the enzyme) were also processed in a similar way.
'A' shows the saturation binding of estradiol to both the enzyme treated and the control naER. The HAP binding assay was carried out as described in "materials and methods' "B 1 represents the E-RAF dependent DNA cellulose binding assay for the enzyme treated as well as the control naER. The E-RAF dependent DNA cellulose binding assay was carried out as described in 'materials and methods'. % C shows the chromatographic elution profiles of control and the enzyme treated naER from a Sephadex G-100 column. The samples were concentrated to 200uJ prior to chromatography on a Sephadex G-100 column. The column was precalibrated with blue dextran, bovine serum albumin, ovalbumin, cytochrome c and glycine. The fractions collected were subjected to HAP binding assay.
In 'A' and 'C the enzyme treated naER has been represented by the open circles while the closed circles represent the control naER. In B' the closed circles represent the enzyme treated naER while the open circles represent the control naER. The purified R-I and R-II receptors were incubated with lOmM ATP at 30oC for 60 minutes prior to their exposure to anti phosphotyrosine IgG. The incubated proteins were chromatographed on a column of anti phosphotyrosine IgG Sepharose equilibrated with lOmM Tris HC1 pH 7.6 containing 12mM monothioglycerol, 6mM MgCl , 20mM NaCl and 0.2mM PMSF. After washing the column with the buffer the proteins bound to the column were eluted with 0.2M glycine pH 2.8. Fractions collected were measured for absorbance at 280nm. The open and closed circles indicate the elution profiles of R-II and R-I receptors respectively.
The inset is a western blot showing the immunorecognition of R-II, but not R-I, by the anti phosphotyrosine IgG. The receptor proteins (naER, R-I and R-II receptors) were labelled with fluorescein isothiocyanate (FITC). The FITC labelled proteins were incubated with purified RNA polymerase II in TEMG buffer for different time intervals at 30oC. The incubation was stopped by cooling the tubes in ice. The complex (receptor-RNA polymerase II) was dissociated following the addition of 0.5M NaCl. The RNA polymerase II was immunoprecipitated by the addition of anti RNA polymerase IgG. The immunoprecipitates, collected following centrifugation, were analysed for fluorescence intensity in a spectrofluorometer.
In the figure the closed circles indicate the % transfer of fluorescence to RNA polymerase from FITC labelled R-II receptor. Open circles represent the transfer from FITC labelled naER and triangles represent that from FITC labelled R-I receptor. The total fluorescence activity associated with the fluorescent labelled protein was taken as 100% activity for this purpose. 'A' and 'B' display data on the autophosphorylation of R-II receptor and of R-I respectively. The numbers on the autoradiogram indicate the concentration (in jig) of the protein used in the incubation medium. Estrogens failed to inhibit R-II autophosphorylation (data not shown).
*O and *D' refers to the effect of E-RAF on the phosphorylation of R-II receptor (C) and naER (D). lOug of the purified receptors were allowed to phosphorylate in the presence or absence of E-RAF (lOug). The numbers 0' and 10' on the autoradiogram indicate protein concentration (in mg) of E-RAF used in the incubation medium.
'E' shows the effect of the tyrosine kinase inhibitor (Tyrphostin 25) on the autophosphorylation of R-II receptor. lOmg of R-II receptor was exposed to different concentrations (uM) of Tyrphostin 25 (indicated by the numbers on the autoradiogram).
*P is an autoradiogram showing the identification of phosphorylated aminoacid associated with the autophosphorylated R-II receptor. The phosphorylated proteins were subjected to acid hydrolysis and the hydrolysates were subjected to paper chromatography as described in materials and methods'. Phospho tyrosine (P-Tyr), phospho serine (P-Ser) and phospho threonine (P-Thr) were used as standards. The paper chromatogram was subjected to autoradiography. 'A' is a non-denaturing gel of the purified enzyme and *B' a 15% SDS gel The RNA polymearse, incubated with the protein kinase assay medium either in the presence or absence of estrogen receptors (R-II or naER) was subjected to SDS-PAGE. The dried gels were subjected to autoradiography (C). 1 and 2 display the subunits phosphorylated in the absence of estradiol. 3 and 4 correspond to those phosphorylated by the R-II in the presence and absence of estradiol respectively. 5 and 6 indicate those phosphorylated by naER in the presence and absence of estradiol. 7 indicate the phosphorylation of subunits in the presence of R-I receptor The arrows (in B) indicat the subunits which were phosphorylated. E-RAF and naER enter the nucleus as constituents of a heterodimer. A nuclear glycopeptidase acts on the naER and the deglycosylated naER dissociates itself from the E-RAF. The hormone bound to the receptor also dissociates due to the decrease in the hormone binding affinity introduced by the deglycosylation process. The modified naER is now designated as the R-II which binds to the RNA polymerase. A, B and C represent the 2-D gels of R-I, naER and R-II respectively. The R-I has a pi of 5.6 and R-II and naER display a pi of 5.2 each. D' is an immunoblot showing the cross-reactivity of R-I, naER and R-II with anti hER (bacterially expressed) polyclonal antibody (SB208). E' is an immunoblot showing the crossreactivity between R-I and the monoclonal antibody against hER (Mabl7).
